Gabelli Downgrades Diebold (DBD) to Hold following Q3; Risks Ahead

Article Related Press Releases (1) Related Articles (1) Stock Quotes (1) Comments (0)

Gabelli downgraded Diebold (NYSE: DBD) from Buy to Hold with a price target of $47.00 (from $54.00) due to operational and end-market risks ahead.

The firm lowered 2013 and ’14 EPS estimates to $2.40 and $2.80, from $2.85 and $3.35 respectively.

"Diebold faced several headwinds in the quarter including lower mix due to higher National account business; project delays in Brazil; the ongoing FCPA investigation and the new Brazil tax assessment; and forecasting issues in North American operations impacting profitability," the analyst comments.

For an analyst ratings summary and ratings history on Diebold click here. For more ratings news on Diebold click here.

Shares of Diebold closed at $30.80 yesterday, with a 52 week range of $28.06-$42.93.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Needham & Company Remains on Sidelines wth Applied Materials (AMAT) Post Q2
• Jefferies Downgrades Limited Brands (LTD) to Underperform; Sees 21% Downside

Create E-mail Alert Related Categories

Analyst EPS Change, Analyst EPS View, Analyst PT Change, Downgrades

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?